Wilms’ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory malignant lymphoma

Click to increase image sizeClick to decrease image size

Acknowlegements

We would like to express our thanks to patients who participated in this study as well as research nurses and coordinators. We would like to thank Mr. Timothy Grose for reviewing and correcting the manuscript.

Author contributions

M.O designed and performed the study and wrote the paper. M.M performed assays. Y.Y performed cell processing. S.O and M.O performed treatment of patients, acquisition and analysis of data.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The study was supported by the Institute for Artificial Organ, Transplantation and Cell Therapy, Sapporo, Japan under Grant #131111.08.